Ocular Therapeutix (OCUL) Change in Account Payables (2013 - 2026)
Ocular Therapeutix (OCUL) posted quarterly Change in Account Payables of $196000.0 for Q2 2026, down 88.68% year-over-year from $1.7 million in Q2 2025, and down 94.73% on a QoQ basis from $3.7 million in Q1 2026.
Ocular Therapeutix (OCUL) Change in Account Payables (2013 - 2026) Analysis & Trends
Ocular Therapeutix has reported Change in Account Payables for 14 years, with the latest figure at $196000.0 in Q2 2026.
- Change in Account Payables for Q2 2026 came in at $196000.0, down 88.68% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.3 million (down 39.92% YoY), and the FY2025 annual result was -$887000.0, down 178.93% from the prior year.
- Change in Account Payables eased to $196000.0 in Q2 2026, from $3.7 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $3.7 million in Q1 2026 and troughed at -$2.4 million in Q2 2024.
- A 5-year average of $148444.4 and a median of $221500.0 in 2023 frame the typical range for Change in Account Payables.
- The widest annual swing landed in 2025, when Change in Account Payables slumped 1308.04%; it then jumped 53028.57% in 2026.
- A 5-year view of Change in Account Payables shows it stood at -$1.1 million in 2022, then jumped by 158.47% to $656000.0 in 2023, then slumped by 82.93% to $112000.0 in 2024, then slumped by 1308.04% to -$1.4 million in 2025, then jumped by 114.49% to $196000.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $196000.0 in Q2 2026, $3.7 million in Q1 2026, and -$1.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ocular Therapeutix | 2.20 Bn | 2.20 Bn | 11.46 Mn | 196,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 196,000.00 |
| Jun 30, 2026 | 196,000.00 |
| Mar 31, 2026 | 3.72 Mn |
| Mar 31, 2026 | 3.72 Mn |
| Dec 31, 2025 | -1.35 Mn |
| Dec 31, 2025 | -1.35 Mn |
| Sep 30, 2025 | -1.27 Mn |
| Sep 30, 2025 | -1.27 Mn |
| Jun 30, 2025 | 1.73 Mn |
| Jun 30, 2025 | 1.73 Mn |
| Mar 31, 2025 | 7,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 112,000.00 |
| Dec 31, 2024 | 112,000.00 |
| Sep 30, 2024 | 297,000.00 |
| Sep 30, 2024 | 297,000.00 |
| Jun 30, 2024 | -2.42 Mn |
| Jun 30, 2024 | -2.42 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Mar 31, 2024 | 1.69 Mn |